(PRNB) |
| 0 (0%) 01-14 13:26 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 101.89 |
| Resistance 1: | 101.06 |
| Pivot price: | 100.01 |
| Support 1: | 99.73 |
| Support 2: | 82.98 |
| 52w High: | |
| 52w Low: |
| EPS | -2.270 |
| Book Value | 10.600 |
| PEG Ratio | 0.00 |
| Gross Profit | 1.058 |
| Profit Margin (%) | -137.82 |
| Operating Margin (%) | -148.35 |
| Return on Assets (ttm) | -16.0 |
| Return on Equity (ttm) | -26.4 |
Sat, 22 Feb 2025
Leven Kali Returns With Jazzy New Single "Are U Still" - EARMILK
Thu, 11 May 2023
PNRB ploughs back into community - Mmegi Online
Tue, 01 Sep 2020
Inside a biotech's buyout for 32% more than the initial offer - The Business Journals
Mon, 17 Aug 2020
Sanofi to acquire MS drug-development partner for $3.68B - drugdiscoverytrends.com
Mon, 17 Aug 2020
Sanofi to acquire Principia Biopharma - GlobeNewswire
Mon, 17 Aug 2020
Sanofi To Acquire Partner Principia Biopharma, Expand MS Treatment Efforts - Investor's Business Daily
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |